Orange Book product · Generic (ANDA)
CALCIUM ACETATE
CALCIUM ACETATE
At a glance
Jun 01, 2012
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 01, 2012
14 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
CALCIUM ACETATE
Strength
667MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 091312
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CALCIUM ACETATE
- 2011PHOSLYRABrand (NDA)
NDA 022581 · FRESENIUS MEDCL CARE
- 2001PHOSLOBrand (NDA)
NDA 021160 · FRESENIUS MEDCL CARE
- 1990PHOSLOBrand (NDA)
NDA 019976 · FRESENIUS MEDCL CARE
- 2023CALCIUM ACETATEGeneric (ANDA)
ANDA 217205 · SQUARE PHARMS
- 2020CALCIUM ACETATEGeneric (ANDA)
ANDA 211038 · SUVEN PHARMS
- 2016CALCIUM ACETATEGeneric (ANDA)
ANDA 203298 · LOTUS PHARM CO LTD
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 203179 · MPP PHARMA
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202127 · LUPIN
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202315 · HERITAGE PHARMS INC
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202885 · HERITAGE PHARMS INC
- 2014CALCIUM ACETATEGeneric (ANDA)
ANDA 201658 · AMNEAL PHARMS
- 2013CALCIUM ACETATEGeneric (ANDA)
ANDA 203135 · INVAGEN PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
